Literature DB >> 1885745

Localization of endogenous activity of phospholipases A and C in Ureaplasma urealyticum.

N S De Silva1, P A Quinn.   

Abstract

Endogenous activities of phospholipases A and C in Ureaplasma urealyticum were assayed in cellular fractions of exponential-phase cells. Enzymatic studies indicated that ATPase activity was localized in the plasma membrane fraction and NADH and NADPH dehydrogenase activities were localized in the cytosol fraction. Studies with purified ureaplasma membranes demonstrated that, of three serovars tested, endogenous phospholipase A1, A2, and C activities were localized in the plasma membrane. Very low levels of activity were observed in the cytosol fractions. Phospholipase A2 activity in the plasma membrane was 3- to 5-fold higher than the activity in the lysates and 60- to 300-fold higher than the activity of phospholipase A1. Phospholipase C was localized mainly in the plasma membrane, with 20% found in the cytosol fraction. The levels of activity were comparable among the three serovars. There was a significantly lower level of activity in cells from the stationary growth phase than in the exponential phase. Significant differences were observed in the phospholipase A activities among the U. urealyticum serovars 3, 4, and 8. Phospholipase A2 activity was twofold higher in serovar 8 membranes, and phospholipase A1 activity was twofold higher in serovar 3 membranes. These results demonstrate that endogenous activities of phospholipase A and C are localized primarily in the plasma membrane fraction of U. urealyticum. The specific activities in the membranes of the phospholipases varied among the three serovars. Phospholipase enzymes may function as virulence factors in U. urealyticum and may vary among the serovars.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885745      PMCID: PMC270141          DOI: 10.1128/jcm.29.7.1498-1503.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Metabolism of glycerolipids. 2. The enzymatic acylation of lysolecithin.

Authors:  W E LANDS
Journal:  J Biol Chem       Date:  1960-08       Impact factor: 5.157

Review 2.  Mycoplasma infection of the fetus and newborn.

Authors:  P A Quinn
Journal:  Prog Clin Biol Res       Date:  1988

3.  Control of sodium fluxes in Mycoplasma gallisepticum.

Authors:  M H Shirvan; S Schuldiner; S Rottem
Journal:  Isr J Med Sci       Date:  1987-05

4.  Characterization of phospholipase A2 of mycoplasma species.

Authors:  S Bhandari; P J Asnani
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

5.  Intrauterine infection with Ureaplasma urealyticum as a cause of fatal neonatal pneumonia.

Authors:  P A Quinn; J E Gillan; T Markestad; M A St John; A Daneman; K I Lie; H C Li; E Czegledy-Nagy; A Klein
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct

6.  A membrane-bound lysophospholipase from Mycoplasma laidlawii strain B.

Authors:  L M van Golde; R N McElhaney; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1971-02-02

7.  Metabolic distinctiveness of ureaplasmas.

Authors:  J D Pollack
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

8.  Lipid interconversions in aging Mycoplasma capricolum cultures.

Authors:  Z Gross; S Rottem
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

9.  Endogenous activity of phospholipases A and C in Ureaplasma urealyticum.

Authors:  N S De Silva; P A Quinn
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

10.  The effect of Mycoplasma hominis and Ureaplasma urealyticum on hamster egg in vitro penetration by human spermatozoa.

Authors:  F Busolo; R Zanchetta
Journal:  Fertil Steril       Date:  1985-01       Impact factor: 7.329

View more
  9 in total

1.  Characterization of phospholipase A1, A2, C activity in Ureaplasma urealyticum membranes.

Authors:  N S DeSilva; P A Quinn
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 2.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

3.  Interaction between pathogenic bacteria and intrauterine leukocytes triggers alternative molecular signaling cascades leading to labor in women.

Authors:  Guadalupe Estrada-Gutierrez; Nardhy Gomez-Lopez; Veronica Zaga-Clavellina; Silvia Giono-Cerezo; Aurora Espejel-Nuñez; Marco Antonio Gonzalez-Jimenez; Salvador Espino y Sosa; David M Olson; Felipe Vadillo-Ortega
Journal:  Infect Immun       Date:  2010-08-30       Impact factor: 3.441

Review 4.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  Mycoplasma pulmonis inhibits electrogenic ion transport across murine tracheal epithelial cell monolayers.

Authors:  L C Lambert; H Q Trummell; A Singh; G H Cassell; R J Bridges
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

Review 6.  Ureaplasma and BPD.

Authors:  Suhas G Kallapur; Boris W Kramer; Alan H Jobe
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

7.  Ureaplasma diversum infection in vitro alters prostaglandin E2 and prostaglandin F2a production by bovine endometrial cells without affecting cell viability.

Authors:  J J Kim; P A Quinn; M A Fortier
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 8.  Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.

Authors:  G H Cassell; K B Waites; H L Watson; D T Crouse; R Harasawa
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

9.  Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Authors:  Vanya Paralanov; Jin Lu; Lynn B Duffy; Donna M Crabb; Susmita Shrivastava; Barbara A Methé; Jason Inman; Shibu Yooseph; Li Xiao; Gail H Cassell; Ken B Waites; John I Glass
Journal:  BMC Microbiol       Date:  2012-05-30       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.